WallStreetZenWallStreetZen

NASDAQ: AMRN
Amarin Corp PLC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Be the first to know when Wall Street analysts revise their AMRN stock forecasts and price targets.

Forecast return on equity

Is AMRN forecast to generate an efficient return?
Company
N/A
Industry
15.8%
Market
35.16%

Forecast return on assets

Is AMRN forecast to generate an efficient return on assets?
Company
N/A
Industry
5.92%

AMRN revenue forecast

What is AMRN's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$214.0M-30.26%
Avg 2 year Forecast
$194.1M-36.77%
Avg 3 year Forecast
$207.0M-32.57%
AMRN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AMRN revenue growth forecast

How is AMRN forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
-13.44%
Industry
8.59%
Market
9.92%
AMRN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AMRN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AMRN vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
AMRN$0.86N/AN/A
SCLX$0.86$12.00+1,293.73%Buy
GRFS$6.27$10.50+67.46%Hold
OGN$18.42$20.00+8.58%Buy
BIIB$202.46$284.95+40.74%Buy
View Top General Drug Manufacturer Stocks

Amarin Stock Forecast FAQ

What is AMRN's revenue growth forecast for 2024-2026?

(NASDAQ: AMRN) Amarin's forecast annual revenue growth rate of -13.44% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 8.59%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Amarin's revenue in 2024 is $306,911,000.On average, 4 Wall Street analysts forecast AMRN's revenue for 2024 to be $87,900,192,072, with the lowest AMRN revenue forecast at $76,015,350,180, and the highest AMRN revenue forecast at $97,123,880,700. On average, 3 Wall Street analysts forecast AMRN's revenue for 2025 to be $79,699,076,226, with the lowest AMRN revenue forecast at $69,280,332,660, and the highest AMRN revenue forecast at $96,043,813,866.

In 2026, AMRN is forecast to generate $84,990,582,369 in revenue, with the lowest revenue forecast at $83,945,422,638 and the highest revenue forecast at $86,035,742,100.

If you're new to stock investing, here's how to buy Amarin stock.

What is AMRN's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: AMRN) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - General industry average of 5.92%.

What is AMRN's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: AMRN) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.